This grant, offered by the NHLBI, aims to support pilot studies that advance the understanding of normal biology and resilience related to heart, lung, blood, and sleep (HLBS) disorders. Research interests include fundamental processes that explain resilience in individuals and contribute to maintaining or restoring normal function. The focus is on furthering the NHLBI Strategic Vision Objective 1 through innovative research approaches. Applications are encouraged from R01-funded investigators to explore new directions in diagnosing and treating HLBS disorders.
Opportunity ID: 310070
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-19-049 |
Funding Opportunity Title: | New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 – Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 01, 2018 |
Last Updated Date: | Nov 01, 2018 |
Original Closing Date for Applications: | Jan 07, 2022 |
Current Closing Date for Applications: | Jan 07, 2022 |
Archive Date: | Feb 12, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public housing authorities/Indian housing authorities Independent school districts State governments Special district governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Small businesses For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The development of more effective means for diagnosing and treating heart, lung, blood, and sleep (HLBS) disorders is often aided bya detailed understanding of normal biology, specifically the nature and operations of the molecular systems and cells that are affected by those diseases. ?Areas of?r?e?s?e?a?r?c?h? ?i?n?t?e?r?e?s?t?include? ?s?t?u?d?i?e?s? ?o?f? ?f?u?n?d?a?m?e?n?t?a?l? ?p?r?o?c?e?s?s?e?s? ?t?h?a?t?explain resilience the capability of some individuals to maintain or restore normal function despite aging or exposurethat causes disease in others.This Program Announcement FOA will support pilot studies by R01-funded investigators in areas of research that advance high priority studies of normal biology and resilience as described by Objective 1 of the NHLBI Strategic Vision. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-19-049.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00246033 | Jan 16, 2019 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259927 | Jan 16, 2019 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270233 | Nov 16, 2021 | Jan 07, 2022 | View |
Package 1
Mandatory forms
310070 RR_SF424_2_0-2.0.pdf
310070 PHS398_CoverPageSupplement_4_0-4.0.pdf
310070 RR_OtherProjectInfo_1_4-1.4.pdf
310070 PerformanceSite_2_0-2.0.pdf
310070 RR_KeyPersonExpanded_2_0-2.0.pdf
310070 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310070 RR_Budget_1_4-1.4.pdf
310070 RR_SubawardBudget30_1_4-1.4.pdf
310070 PHS398_ModularBudget_1_2-1.2.pdf
310070 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
310070 RR_SF424_2_0-2.0.pdf
310070 PHS398_CoverPageSupplement_5_0-5.0.pdf
310070 RR_OtherProjectInfo_1_4-1.4.pdf
310070 PerformanceSite_2_0-2.0.pdf
310070 RR_KeyPersonExpanded_2_0-2.0.pdf
310070 PHS398_ResearchPlan_4_0-4.0.pdf
310070 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
310070 RR_Budget_1_4-1.4.pdf
310070 RR_SubawardBudget30_1_4-1.4.pdf
310070 PHS398_ModularBudget_1_2-1.2.pdf
310070 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
310070 RR_SF424_5_0-5.0.pdf
310070 PHS398_CoverPageSupplement_5_0-5.0.pdf
310070 RR_OtherProjectInfo_1_4-1.4.pdf
310070 PerformanceSite_4_0-4.0.pdf
310070 RR_KeyPersonExpanded_4_0-4.0.pdf
310070 PHS398_ResearchPlan_4_0-4.0.pdf
310070 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
310070 RR_Budget_3_0-3.0.pdf
310070 RR_SubawardBudget30_3_0-3.0.pdf
310070 PHS398_ModularBudget_1_2-1.2.pdf
310070 PHS_AssignmentRequestForm_3_0-3.0.pdf